MoneyWorks4Me

Choksi Laboratories Ltd (526546)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526546 NSE: Business Support | Small Cap | Choksi Laboratories Share Price

₹190.45 8.45 (4.64%)

As on 11-Sep'26 16:59

Choksi Laboratories Ltd (526546)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526546 NSE: Business Support | Small Cap | Choksi Laboratories Share Price

₹190.45 8.45 (4.64%)

As on 11-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹133 Cr.
Current Price
₹190.5
52-Week Low / High
₹82 / 215
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
27
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
13.84%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
31.48%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹7 Cr.
Face Value
₹10
All Time Low / High
₹0.50 / 236.70

Choksi Laboratories stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Overvalued

Price Trend

Weak
Q.1 Is Choksi Laboratories Ltd a good quality company?
Choksi Laboratories Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Choksi Laboratories Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Choksi Laboratories Ltd vs industry peers?
Choksi Laboratories Ltd revenue CAGR is %, compared to the industry median CAGR of -1.49%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Choksi Laboratories Ltd?
Promoters hold 31.48% of the Choksi Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Choksi Laboratories Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 30% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Choksi Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.3%8.4%10.5%10.1%-8.3%0%6.8%13.9%9.2%9.5%-
Value Creation
Index
-0.5-0.4-0.3-0.3-1.6-1.0-0.50.0-0.3-0.3-

Growth Parameters

Sales 22.328.831.233.828.225.73034.436.741.847
Sales YoY Gr.-29%8.5%8.2%-16.6%-8.8%16.9%14.7%6.6%13.8%-
Adj EPS 1.20.91.92.3-2.4-3.70.32.31.62.23.1
YoY Gr.--20.7%110.9%18%-206.1%NANA673.3%-31%36.3%-
BVPS (₹) 28.830.332.234.52925.525.730.331.933.937.6
Adj Net
Profit
0.80.61.41.6-1.7-2.60.21.61.11.52
Cash Flow from Ops. 6.76.66.36.92.95.97.98.311.611.8-
Debt/CF from Ops. 21.722.4116.14.43.72.52.4-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 7.2%8.2%11.6%13.8%
Adj EPS 7.3%NA93.7%36.3%
BVPS1.8%3.1%9.7%6.3%
Share Price 30% 57.7% 48.7% -5.4%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
4.13.16.26.9-7.7-13.71.28.35.26.68.7
Op. Profit
Mgn %
23.316.620.321.512.616.129.729.82827.126.8
Net Profit
Mgn %
3.62.24.34.7-6-10.10.74.733.64.6
Debt to
Equity
0.70.50.60.71.621.91.41.31.2-
Working Cap
Days
24418114917422121917115014213669
Cash Conv.
Cycle
6730171282045727046-20

Valuation of Choksi Laboratories - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Choksi Laboratories Ltd FAQs

The current trading price of Choksi Laboratories on 11-Sep-2026 16:59 is ₹190.4.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of Choksi Laboratories stood at ₹132.7 Cr

The latest P/E ratio of Choksi Laboratories as of 10-Sep-2026 is 61.39.

The latest P/B ratio of Choksi Laboratories as of 10-Sep-2026 is 5.07.

The 52-week high of Choksi Laboratories is ₹214.9 and the 52-week low is ₹81.85.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Choksi Laboratories is ₹46.83 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Choksi Laboratories Ltd is a below average quality company.

The key valuation ratios of Choksi Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Choksi Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Choksi Laboratories Ltd

Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

CLL is a contract testing and analysis laboratory based in Indore, Central India. It analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals etc. It also help industries in their research processes. Its environment consultancy division helps firms in keeping the environment clean and free from pollution.

CLL was the first to develop Vendor Assessment programme in the edible oil extraction industry. The first to start water and soil analysis in Central India, also the first to start instrument calibration services for organizations that were targeting ISO certification or had already achieved it. The only one to commission and run, probably the largest Effluent Treatment Plant in India, at ONGC's Amod oil rig.

Quality products are a function of better raw materials and quality procedures.  CLL currently has facilities for analysis of over 1000 products and materials, with more being added every day.

A vast updated database of test specifications derived from AOAC, USP, BP, CP, EP, IP, IS, EPA, PFA, Food Chemicals Codex, AOCS, and several in-house methods, serves a wide spectrum of products and materials – pharmaceutical raw materials and formulations, agro products and their derivatives, fertilizers, pesticides, edible and industrial oils, chemicals, paints and dyes.

Last year, CLL provided its services to more than 1,000 customers world-wide. Driving this accelerated growth is a hard-working people-force of 200+ CLL personnel. They are young (The average age in CLL is below 30 years). They are determined. And they have a huge appetite for learning. Mostly from the University town of Indore, these graduates undergo a rigorous six month training at their lab. Once inducted, continuous training programmes take over - both internal as well as external. And finally the long painful process of getting these qualified personnel approved as FDA, BIS, MoEF - whatever their respective fields demand. In fact, one thing that they are quite known for is their excellent human resource pool. So much so that the surrounding companies keep playing bait to our experienced staff. Though it is quite a nuisance at times, it also does us proud when they are recognized and accepted in regional companies, and multinationals alike.

Services offered by the company:

  • Contract Laboratory Services (CLS):-Pharmaceutical Analysis-Food & Beverages Analysis-Water Analysis-Construction Material Analysis
  • Instrument Calibration & Validation Services
  • Environment Management Services
  • Clinical Research
  • Consultancy  
  • Assaying & Hallmarking

Clientele:

  • IPCA Laboratories
  • Nicholas Piramal India Ltd.
  • Serum Institute of India
  • Famycare India

Achievements/ recognition:

  • CLL is certified by BIS (Bureau of Indian Standards), FDA (Food and Drugs control Administration), MoEF (Ministry of Environment & Forests), State Pollution Control Boards (Gujarat and Madhya Pradesh State Pollution Control Boards), Department of Health(MP), Agricultural Marketing Advisor (AGMARK - GOI), and several other regulatory bodies.
  • CLL has also been accredited by NABL (National Accreditation Board for testing & calibration Laboratories). This is internationally recognized through ILAC (International Laboratory Accreditation Committee) and is based on ISO/IEC 17025 guidelines.
  • ISO/IEC 17025 : 2005Ministry of Environment & Forests (MoEF), India
  • Bureau of Indian Standards (BIS), India
  • Export Inspection Council (EIC), India
  • AGMARK, IndiaGold & Silver Assaying & Hallmarking Center (approved by Bureau of Indian Standards)
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now